News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,927 Results
Type
Article (8017)
Company Profile (141)
Press Release (477768)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166746)
Career Advice (305)
Deals (25738)
Drug Delivery (7)
Drug Development (52877)
Employer Resources (14)
FDA (9761)
Job Trends (8574)
News (238194)
Policy (17907)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (491)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33161)
ALS (108)
Alzheimer's disease (985)
Antibody-drug conjugate (ADC) (281)
Approvals (10405)
Artificial intelligence (331)
ASCO (159)
Autoimmune disease (220)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6963)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (89)
Bladder cancer (139)
Brain cancer (31)
Breast cancer (518)
Cancer (3750)
Cardiovascular disease (226)
Career advice (246)
Career pathing (1)
CAR-T (178)
CDMO (14)
Celiac Disease (1)
Cell therapy (486)
Cervical cancer (35)
Clinical research (48035)
Collaboration (1275)
Commercialization (3)
Compensation (1530)
Complete response letters (34)
COVID-19 (764)
CRISPR (64)
C-suite (801)
Cystic fibrosis (87)
Data (5843)
Denatured (4)
Depression (106)
Dermatology (67)
Diabetes (352)
Diagnostics (4214)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73747)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88103)
Executive appointments (714)
FDA (12479)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (943)
Gene editing (126)
Generative AI (11)
Gene therapy (331)
GLP-1 (294)
Government (956)
Grass and pollen (2)
Guidances (281)
Healthcare (9379)
Hematology (94)
HIV (55)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (103)
Immuno-oncology (61)
Indications (161)
Infectious disease (956)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (260)
Interviews (42)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (18)
Liver cancer (45)
Longevity (19)
Lung cancer (537)
Lymphoma (257)
Machine learning (28)
Management (3)
Manufacturing (564)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8677)
Medtech (8834)
Mergers & acquisitions (14408)
Metabolic disorders (724)
mRNA (61)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (226)
Neuropsychiatric disorders (40)
Neuroscience (1865)
NextGen: Class of 2026 (3153)
Non-profit (849)
Obesity (231)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (206)
Parkinson's disease (205)
Partnered (12)
Patents (495)
Patient recruitment (530)
Patient selection (2)
Peanut (32)
People (41369)
Peptides (2)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15517)
Phase 2 (21450)
Phase 3 (14462)
Pipeline (7676)
Policy (18)
Postmarket research (1572)
Preclinical (6553)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (586)
Real estate (3024)
Recruiting (6)
Regenerative medicine (1)
Regulatory (14951)
Reports (23)
Research institute (585)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (161)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (51)
Vaccines (333)
Venture capital (17)
Weight loss (75)
Women's health (87)
Date
Today (61)
Last 7 days (319)
Last 30 days (1414)
Last 365 days (19119)
2026 (13557)
2025 (19251)
2024 (22986)
2023 (26538)
2022 (34593)
2021 (37179)
2020 (33469)
2019 (23277)
2018 (17468)
2017 (18765)
2016 (17917)
2015 (24265)
2014 (21679)
2013 (18138)
2012 (20221)
2011 (20441)
2010 (20332)
Location
Africa (229)
Alabama (77)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (17957)
Australia (2107)
California (12331)
Canada (3227)
China (543)
Colorado (496)
Connecticut (427)
Delaware (214)
Europe (24695)
Florida (1850)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (727)
India (52)
Indiana (323)
Iowa (16)
Japan (421)
Kansas (102)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1228)
Massachusetts (8092)
Michigan (314)
Minnesota (572)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (122)
New Hampshire (60)
New Jersey (2687)
New Mexico (12)
New York (2890)
North Carolina (1314)
North Dakota (4)
Northern California (6202)
Ohio (293)
Oklahoma (14)
Oregon (18)
Pennsylvania (2295)
Puerto Rico (21)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5129)
Tennessee (125)
Texas (1999)
United States (39971)
Utah (371)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (955)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,927 Results for "baebies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Baebies Receives FDA 510(k) Clearance for G6PD Test on FINDER Platform
Baebies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) deficiency.
November 9, 2022
·
5 min read
Bio NC
Baebies Earns CE Mark for FINDER SARS-CoV-2 Point-of-Care Testing Platform
Baebies® announced it has received CE Mark for its FINDER® SARS-CoV-2 point-of-care test, which performs RT-PCR testing to detect SARS-CoV-2 on the FINDER 1.5 Instrument.
March 24, 2022
·
2 min read
Deals
Baebies Awarded $2.7 Million NIH Grant for Rapid, Near-patient Heparin Monitoring Requiring Low Sample Volume
Baebies, a growth-stage company developing innovative products to enable early disease detection and multifunctional diagnostics for syndromic testing, was recently awarded $2.7 million in a Phase IIB SBIR grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.
May 19, 2021
·
4 min read
Deals
Baebies Awarded up to $11.6 Million from CARB-X for the Development of a Diagnostic Platform with Rapid Results for Sepsis
Baebies, a growth-stage company developing innovative products to enable early disease detection and comprehensive diagnosis, announced that CARB-X has awarded the company up to $11.6 million in non-dilutive funding.
April 20, 2021
·
5 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Allumiqs Solutions Inc. and Allumiqs Corporation
September 15, 2026
·
1 min read
Bio NC
Baebies Announces CE Mark for Newborn Screening Assays for Galactosemia and Biotinidase Deficiency on SEEKER
Baebies, a growth-stage company developing diagnostic products to provide a healthy start for children everywhere, announced that it has met all requirements for CE mark under the IVD Directive for newborn screening assays on SEEKER® for galactosemia and biotinidase deficiency.
May 29, 2020
·
2 min read
FDA
Baebies Announces FDA Acknowledgement of Emergency Use Notification for FINDER 1.5 Instrument and FINDER SARS-CoV-2 Test – RT-PCR within 17 Minutes
Baebies , a growth-stage company developing innovative products to enable early disease detection and comprehensive diagnosis, today announced that the U.S. Food & Drug Administration (FDA) acknowledged the company’s Emergency Use Notification (EUN) for an RT-PCR test to detect SARS-CoV-2 on the FINDER ® 1.5 Instrument .
April 6, 2021
·
3 min read
Policy
Baebies Announces CE Mark for FINDER, an Innovative Near-Patient Testing Platform for Glucose-6-Phosphate Dehydrogenase
Baebies is pleased to announce that FINDERTM, a near-patient testing platform, now has CE Mark as an In Vitro Diagnostic device and is commercially available in Europe and other countries that recognize CE Mark.
December 17, 2019
·
3 min read
Press Releases
Carlsmed, Inc. Announces Chief Operating Officer Appointment
September 8, 2026
·
2 min read
1 of 48,593
Next
